Bausch Health Companies BHC
NYSE BHC
$6.82 -0.07 (-1.09%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026)

Bausch Health Companies (BHC) posted Income towards Parent Company of $260.0 million for Q2 2026, up 118.17% sequentially from -$1.4 billion in Q1 2026, and up 103.12% YoY from $128.0 million in Q2 2025.

Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Income towards Parent Company for 18 years, with the latest figure at $260.0 million in Q2 2026.

  • Quarterly Income towards Parent Company rose 103.12% year-over-year to $260.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 2377.08% YoY) and the FY2025 annual result came in at $120.0 million, up 266.67% from the prior year.
  • Income towards Parent Company grew to $260.0 million in Q2 2026 per BHC's latest filing, from -$1.4 billion in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $403.0 million in Q3 2022 and troughed at -$1.4 billion in Q1 2026.
  • A 5-year average of -$108.1 million and a median of -$71.5 million in 2022 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2025 and 2026: Income towards Parent Company surged 12900.0% in 2025, then slumped 1563.95% in 2026.
  • Over 5 years, Income towards Parent Company stood at -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then surged by 352.43% to $260.0 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $260.0 million, -$1.4 billion, and -$103.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Bausch Health Companies 2.56 Bn 725.13 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 260.00 Mn
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn